Company profile: EpiBiome
1.1 - Company Overview
Company description
- Provider of precision microbiome engineering focused on developing alternatives to small-molecule antibiotics for use in healthcare, veterinary, and agriculture industries to address antibiotic resistance.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EpiBiome
Oxford BioDynamics
HQ: United Kingdom
Website
- Description: Provider of epigenetic biomarker research and development solutions for pharma and biotech via its proprietary EpiSwitch platform, offering blood tests such as EpiSwitch PSE for prostate cancer risk, CiRT for checkpoint inhibitor therapy success, and CST for COVID-19 severity, plus genome mapping tools including EpiSwitch Platform, Explorer Array Kit, and EpiSwitch Portal for diagnostics, prognostics, and health outcome insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford BioDynamics company profile →
Treos Bio
HQ: United Kingdom
Website
- Description: Provider of computational immunology solutions that predict in silico likely responders to cancer immunotherapies and design next-generation targeted immunotherapies tailored to patient genetics; offers PolyPEPI1018 for metastatic colorectal cancer (developed without need for tumor biopsy), PEPI Panel to create personalized therapies based on tumor type and HLA genotype, PolyPEPI-SCoV-2 preventive vaccine, and PEPI Test predicting peptide-specific T cell responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Treos Bio company profile →
Mammoth Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-based diagnostics, therapeutics, and protein discovery solutions. The DETECTR Platform delivers instrument-free nucleic acid detection for disease; therapeutics offer precision genome editing using novel CRISPR-Cas enzymes; and a proprietary platform discovers new CRISPR systems and Cas proteins for applications in research, agriculture, and biodefense.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mammoth Biosciences company profile →
Agritope
HQ: United States
Website
- Description: Provider of new fruit and vegetable plant varieties for the fresh produce industry, utilizing patented ethylene control technology to develop fruits and vegetables resistant to the decaying effects of ethylene.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agritope company profile →
Nebula Genomics
HQ: United States
Website
- Description: Provider of blockchain-enabled whole genome sequencing (30x and 100x coverage) and a trusted genomic and health data marketplace that ensures consumer data control. Offers Nebula Explore reporting membership, a curated research library, genome exploration tools, and deep genetic ancestry using full mtDNA and Y-DNA sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nebula Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EpiBiome
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EpiBiome
2.2 - Growth funds investing in similar companies to EpiBiome
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EpiBiome
4.2 - Public trading comparable groups for EpiBiome
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →